Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples